Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Equity Ratio (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Equity Ratio for 13 consecutive years, with 0.15 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 38.75% year-over-year to 0.15, compared with a TTM value of 0.15 through Sep 2025, down 38.75%, and an annual FY2024 reading of 0.27, down 17.41% over the prior year.
  • Equity Ratio was 0.15 for Q3 2025 at Tandem Diabetes Care, roughly flat from 0.15 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.48 in Q4 2021 and bottomed at 0.15 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.33, with a median of 0.35 recorded in 2023.
  • The sharpest move saw Equity Ratio grew 3.68% in 2022, then plummeted 38.99% in 2025.
  • Year by year, Equity Ratio stood at 0.48 in 2021, then decreased by 12.67% to 0.42 in 2022, then dropped by 21.22% to 0.33 in 2023, then dropped by 17.41% to 0.27 in 2024, then plummeted by 44.09% to 0.15 in 2025.
  • Business Quant data shows Equity Ratio for TNDM at 0.15 in Q3 2025, 0.15 in Q2 2025, and 0.17 in Q1 2025.